Cubist Systematic Strategies, LLC Abbott Laboratories Put Options Transaction History

Cubist Systematic Strategies, LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $3.41 Million - $4.03 Million	-34,100 Reduced 34.13%	65,800 $7.5 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $9.29 Million - $10.4 Million	92,200 Added 1197.4%	99,900 $10.4 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $262,848 - $290,304	2,400 Added 45.28%	7,700 $875,000
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $1.02 Million - $1.25 Million	-11,300 Reduced 68.07%	5,300 $583,000
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $8.5 Million - $10.2 Million	-89,000 Reduced 84.28%	16,600 $1.61 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $2.16 Million - $2.4 Million	-21,400 Reduced 16.85%	105,600 $11.5 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $5.3 Million - $6.24 Million	54,700 Added 75.66%	127,000 $12.9 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $5.92 Million - $6.95 Million	62,300 Added 623.0%	72,300 $7.94 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $967,600 - $1.12 Million	10,000 New	10,000 $968,000

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.